Mark N Stein

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.

Oliver Sartor, Susan Halabi, Lawrence H Schwartz, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma.

Keith T Flaherty, Paul S Meltzer, Maria J Merino, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012.

Bruce Montgomery, Javed Siddiqui, Walter M Stadler, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer.

Gyan Bhanot, Shridar Ganesan, Hua Zhong, 2016, The Journal of clinical investigation.